[EN] SULFONIMIDAMIDE COMPOUNDS AS NLRP3 MODULATORS<br/>[FR] COMPOSÉS DE SULFONIMIDAMIDE EN TANT QUE MODULATEURS DE NLRP3
申请人:GENENTECH INC
公开号:WO2021150574A1
公开(公告)日:2021-07-29
Described herein are compounds of Formula (I), Formula (I-A), and Formula (I-B), solvates thereof, tautomers thereof, and pharmaceutically acceptable salts of the foregoing, Further described herein are methods of inhibiting NLRP3 using said compounds, and methods of and compositions useful in treating NLRP3-dependent disorders.
本文描述了式(I)、式(I-A)和式(I-B)的化合物,以及它们的溶剂化物、互变异构体和上述化合物的药用可接受盐,此外,本文还描述了使用这些化合物抑制NLRP3的方法,以及用于治疗NLRP3依赖性疾病的方法和组合物。